KCNA6 antisense RNA 1 (KCNA6-AS1)

KCNA6 antisense RNA 1 (KCNA6-AS1) is a long non-coding RNA (lncRNA) transcribed from the genomic region antisense to the KCNA6 gene, which encodes the potassium voltage-gated channel subfamily A member 6 (Kv1.6)[3][4]. There is no direct evidence in the literature that KCNA6-AS1 itself acts as a therapeutic target, receptor, enzyme, transporter, or other classical druggable protein class. Antisense RNAs typically function by regulating the expression of their sense gene counterparts—potentially via transcriptional interference, chromatin modification, or RNA stability modulation—but the specific biological roles of KCNA6-AS1 have not been experimentally established. Based on the properties of other antisense lncRNAs, KCNA6-AS1 may participate in the regulation of KCNA6 gene expression or related pathways, but details remain uncharacterized in public sources[3][4]. No established disease associations, interacting drugs, or biomarker roles have been reported for KCNA6-AS1. Note: - *KCNA6* (not KCNA6-AS1) encodes a potassium channel protein implicated in neuronal excitability, sensory modulation, and diseases such as epilepsy and pain[1][2][5], but KCNA6-AS1 is an antisense RNA, not the protein coding gene or channel. - There is no evidence from current sources that KCNA6-AS1 is misspelled, nor that it is a receptor, enzyme, transporter, or directly druggable target. - If you intended the protein channel, the correct canonical name would be "Potassium voltage-gated channel subfamily A member 6 (Kv1.6)"; for the antisense RNA, use "KCNA6 antisense RNA 1 (KCNA6-AS1)"[2].